Thomas F. Farb - 15 Nov 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 15 Nov 2021
Net transaction value: +$30
SEC form: 4
Accepted by SEC: 02 Dec 2021, 15:12:19 UTC
Prior SEC filing: 12 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ Erika L. Eves for Thomas F. Farb, by power of attorney

Key filing fact

Thomas F. Farb filed Form 4 for NAVIDEA BIOPHARMACEUTICALS, INC. on 02 Dec 2021.

Key facts

This page summarizes Thomas F. Farb's Form 4 filing for NAVIDEA BIOPHARMACEUTICALS, INC..
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Dec 2021, 15:12.

Change

Previous filing in this sequence was filed on 12 Nov 2021.
Current net transaction value: +$30.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAVB transaction

Common Stock

Award

Transaction value: $30
Shares: +30,000
Change %
Price: $0.001000^*
Shares after: 30,000
Date: 15 Nov 2021
Ownership: Direct
Footnotes: F1

NAVB transaction

Common Stock

Award

Transaction value: $0
Shares: +2,175
Change %: +7.2%
Price: $0.000000
Shares after: 32,175
Date: 15 Nov 2021
Ownership: Direct
Footnotes: F2

NAVB transaction

Common Stock

Award

Transaction value: $0
Shares: +1,250
Change %: +3.9%
Price: $0.000000
Shares after: 33,425
Date: 30 Nov 2021
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.

Footnote F2

Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.

Footnote F3

Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.